Stockscreener 앱 받기
1.15
0.00%
0.00
시간 외 거래:
1.13
-0.02
-1.74%
전일 마감가:
$1.15
열려 있는:
$1.15
하루 거래량:
587.73K
Relative Volume:
0.48
시가총액:
$195.92M
수익:
$4.71M
순이익/손실:
$-58.01M
주가수익비율:
-1.3966
EPS:
-0.8234
순현금흐름:
$-46.68M
1주 성능:
-4.17%
1개월 성능:
-20.14%
6개월 성능:
+13.86%
1년 성능:
-22.82%
1일 변동 폭
$1.14
$1.1898
1주일 범위
$1.09
$1.25
52주 변동 폭
$0.9495
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
명칭
Lucid Diagnostics Inc
전화
212 949 4319
주소
360 MADISON AVENUE, NEW YORK
Compare LUCD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.15 | 195.92M | 4.71M | -58.01M | -46.68M | -0.8234 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-27 | 개시 | Ascendiant Capital Markets | Buy |
| 2021-11-08 | 개시 | BTIG Research | Buy |
| 2021-11-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-11-08 | 개시 | Needham | Buy |
Lucid Diagnostics Inc 주식(LUCD)의 최신 뉴스
Lucid Diagnostics Inc. (NASDAQ:LUCD) Short Interest Update - MarketBeat
Dow Update: Can Lucid Diagnostics Inc be recession proof2026 Key Highlights & Accurate Intraday Trade Tips - baoquankhu1.vn
Lucid Diagnostics’ Earnings Call: Momentum Amid Cash Strain - The Globe and Mail
LUCD: BTIG Reiterates Buy Rating with $2.50 Price Target | LUCD Stock News - gurufocus.com
Profit Review: Whats the MACD signal for Lucid Diagnostics Inc2026 Trends & Scalable Portfolio Growth Ideas - baoquankhu1.vn
PAVmed Reports 2025 Financial Results, Strengthens Capital Structure, and Expands Medical Device Portfolio Under New Leadership - Minichart
Lucid Diagnostics (NASDAQ:LUCD) Earns Buy Rating from BTIG Research - MarketBeat
PAVmed (NASDAQ: PAVM) overhauls capital structure and reports 2025 results - Stock Titan
Lucid Diagnostics (LUCD) Earnings Transcript - AOL.com
Cancer screening test wins VA access for 9 million veterans - Stock Titan
BTIG reiterates Lucid Diagnostics stock rating on Q4 beat By Investing.com - Investing.com Canada
BTIG reiterates Lucid Diagnostics stock rating on Q4 beat - Investing.com
Lucid Diagnostics Inc. (LUCD) reports Q4 loss, beats revenue estimates - MSN
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
Lucid Diagnostics non-GAAP adjusted loss hits USD 12.6M in Q4 2025 - Medical Buyer
Lucid Diagnostics (NASDAQ:LUCD) Rating Increased to Hold at Wall Street Zen - MarketBeat
Valuation Update: What is the long term forecast for Lucid Diagnostics Inc stockQuarterly Trade Review & Stepwise Trade Execution Plans - baoquankhu1.vn
PAVmed (PAVM) outlines going concern risk, Nasdaq compliance and growth plans - stocktitan.net
Lucid Diagnostics (NASDAQ:LUCD) Issues Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2025 Earnings Call Transcript - Insider Monkey
[EFFECT] Lucid Diagnostics Inc. SEC Filing - Stock Titan
Lucid Diagnostics Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:LUCD) 2026-03-27 - Seeking Alpha
Lucid Diagnostics signals expanded VA market access and 29% sequential test volume growth while targeting Medicare and commercial payer wins - MSN
Lucid Diagnostics Reports 2025 Financial Results, Expands EsoGuard Access with VA Contract and Positive Real-World Data - Minichart
Lucid Diagnostics (NASDAQ: LUCD) launches ATM program to sell up to $25M - Stock Titan
Lucid Diagnostics Inc (LUCD) Q4 2025 Earnings Call Highlights: Strong Test Volume Growth and ... By GuruFocus - Investing.com Canada
Needham reiterates Buy on Lucid Diagnostics stock, $3 target By Investing.com - Investing.com Australia
The Dixie Group Q4 2025 Financial Review - AlphaStreet
Lucid Diagnostics Q4 2025 Earnings Call Transcript - MarketBeat
Lucid Diagnostics Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Needham & Company LLC Reiterates Buy Rating for Lucid Diagnostics (NASDAQ:LUCD) - MarketBeat
Needham reiterates Buy on Lucid Diagnostics stock, $3 target - Investing.com
LUCD: Test volume and revenue surged, with Medicare and VA poised to drive future growth - TradingView
Lucid Diagnostics Provides Business Update and Reports Fourth Qu - GuruFocus
Lucid Diagnostics Inc. (LUCD) Reports Q4 Earnings - AlphaStreet
LUCD: Strong Q4 growth, VA contract, and imminent Medicare coverage position for accelerated revenue - TradingView
Lucid Diagnostics Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: Lucid Diagnostics Q4 2025 sees stock rise despite EPS miss By Investing.com - za.investing.com
Earnings call transcript: Lucid Diagnostics Q4 2025 sees stock rise despite EPS miss - Investing.com
Lucid Diagnostics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Lucid Diagnostics reports Q4 revenue of $1.5M, VA contract By Investing.com - in.investing.com
Canaccord reiterates Buy on Lucid Diagnostics stock, $3 target By Investing.com - in.investing.com
Lucid Diagnostics Reports Q4 2025 Results, Highlights VA Contract - TipRanks
Lucid Diagnostics reports Q4 revenue of $1.5M, VA contract - investing.com
Canaccord reiterates Buy on Lucid Diagnostics stock, $3 target - Investing.com
Lucid Diagnostics (Nasdaq: LUCD) reports 2025 loss, VA contract win - Stock Titan
Press Release: Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results - Moomoo
Lucid Diagnostics (NASDAQ: LUCD) adds $25M ATM to $175M shelf - Stock Titan
Lucid Diagnostics Inc. (LUCD) Stock Rises on Q4 2025 Earnings - quiverquant.com
Lucid Diagnostics 2025 10-K: Revenue $4.7M, Net Loss $58.0M - TradingView
Lucid Diagnostics Inc (LUCD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Lucid Diagnostics Inc 주식 (LUCD) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Matheis Dennis | Director |
May 20 '25 |
Buy |
1.29 |
187,098 |
242,292 |
187,098 |
| Matheis Dennis | Director |
May 21 '25 |
Buy |
1.32 |
129,684 |
171,520 |
316,782 |
| Matheis Dennis | Director |
May 22 '25 |
Buy |
1.32 |
33,218 |
43,795 |
350,000 |
2.03%
자본화:
|
볼륨(24시간):